Small Molecule Stabilizers as a Potential Treatment for Transthyretin Familial Amyloid Polyneuropathy - NIDDK
hATTR Amyloidosis Treatments: Are They Safe and Effective Long Term? | MyAmyloidosisTeam
Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs | SpringerLink
Frontiers | Current and potential therapeutic strategies for transthyretin cardiac amyloidosis
Brain Sciences | Free Full-Text | Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade | PNAS
RNA-targeting and gene editing therapies for transthyretin amyloidosis | Nature Reviews Cardiology
IJMS | Free Full-Text | Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy
Interactions of tolcapone analogues as stabilizers of the amyloidogenic protein transthyretin - ScienceDirect
AG10 binds to TTR and stabilizes it in buffer. (A) Chemical structures... | Download Scientific Diagram
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade | PNAS
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms | JACC: CardioOncology
Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis
Frontiers | Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials
The Battle For Best-In-Class In ATTR Has Begun (NASDAQ:ALNY) | Seeking Alpha
Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD | Scientific Reports
Pharmaceuticals | Free Full-Text | Tegsedi (Inotersen): An Antisense Oligonucleotide Approved for the Treatment of Adult Patients with Hereditary Transthyretin Amyloidosis
ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review - ScienceDirect
Optimization of kinetic stabilizers of tetrameric transthyretin: A prospective ligand efficiency-guided approach - ScienceDirect
Emerging Therapies for Transthyretin Cardiac Amyloidosis Could Herald a New Era for the Treatment of HFPEF - American College of Cardiology
Conventional Molecular Dynamics and Metadynamics Simulation Studies of the Binding and Unbinding Mechanism of TTR Stabilizers AG10 and Tafamidis | ACS Chemical Neuroscience
Frontiers | Modulation of the Mechanisms Driving Transthyretin Amyloidosis
Frontiers | Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy
